Environmental enrichment fails to rescue working memory deficits, neuron loss, and neurogenesis in APP/PS1KI mice

被引:78
作者
Cotel, Marie-Caroline
Jawhar, Sadim
Christensen, Ditte Z.
Bayer, Thomas A.
Wirths, Oliver [1 ]
机构
[1] Univ Goettingen, Div Mol Psychiat, Dept Psychiat, D-37075 Gottingen, Germany
关键词
Alzheimer; Axonopathy; Behavior; Enriched environment; Intraneuronal A beta; Neurogenesis; Neuron loss; Transgenic mice; Amyloid; TRANSGENIC MOUSE MODEL; ADULT HIPPOCAMPAL NEUROGENESIS; AMYLOID PRECURSOR PROTEIN; A-BETA DEPOSITION; ALZHEIMERS-DISEASE; PHYSICAL-ACTIVITY; DENTATE GYRUS; IMPROVES COGNITION; PLAQUE-FORMATION; ACCUMULATION;
D O I
10.1016/j.neurobiolaging.2010.02.012
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Environmental enrichment has been used in a variety of transgenic mouse models of Alzheimer's disease (AD), however, with conflicting results. Here we studied the influence of environmental enrichment in a severely affected AD mouse model, showing a multiplicity of pathological alterations including hippocampal neuron loss. APP/PS1KI and wild type (WT) control mice were housed under standard conditions or in enriched cages equipped with various objects and running wheels. Amyloid plaque load, motor and working memory performance, axonopathy, as well as CA1 neuron number and hippocampal neurogenesis were assessed. Although a partial improvement in motor performance was observed, 4 months of enriched housing showed no beneficial effects in terms of working memory, A beta plaque pathology, or neuron loss in APP/PS1KI mice. In addition, no changes in hippocampal neurogenesis and even an aggravation of the axonal phenotype were detected with a tendency toward a premature death. The APP/PS1KI model represents a model for mild to severe AD showing early behavioral deficits starting at 2 months of age with fast deterioration. Therefore our data might suggest that physical activity and enriched environment might be more beneficial in patients with mild cognitive impairment than in patients with incipient AD. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:96 / 107
页数:12
相关论文
共 56 条
[1]   Walking and dementia in physically capable elderly men [J].
Abbott, RD ;
White, LR ;
Ross, GW ;
Masaki, KH ;
Curb, JD ;
Petrovitch, H .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (12) :1447-1453
[2]   Voluntary exercise decreases amyloid load in a transgenic model of Alzheimer's disease [J].
Adlard, PA ;
Perreau, VM ;
Pop, V ;
Cotman, CW .
JOURNAL OF NEUROSCIENCE, 2005, 25 (17) :4217-4221
[3]   Reduction of amyloid angiopathy and Aβ plaque burden after enriched housing in TgCRND8 mice -: Involevement of multiple pathways [J].
Ambree, Oliver ;
Leimer, Uwe ;
Herring, Arne ;
Goertz, Nicole ;
Sachser, Norbert ;
Heneka, Michael T. ;
Paulus, Werner ;
Keyvani, Kathy .
AMERICAN JOURNAL OF PATHOLOGY, 2006, 169 (02) :544-552
[4]   Environmental enrichment improves cognition in aged Alzheimer's transgenic mice despite stable β-amyloid deposition [J].
Arendash, GW ;
Garcia, MF ;
Costa, DA ;
Cracchiolo, JR ;
Wefes, IM ;
Potter, H .
NEUROREPORT, 2004, 15 (11) :1751-1754
[5]   Behavioral assessment of Alzheimer's transgenic mice following long-term Aβ vaccination:: Task specificity and correlations between Aβ deposition and spatial memory [J].
Arendash, GW ;
Gordon, MN ;
Diamond, DM ;
Austin, LA ;
Hatcher, JM ;
Jantzen, P ;
Dicarlo, G ;
Wilcock, D ;
Morgan, D .
DNA AND CELL BIOLOGY, 2001, 20 (11) :737-744
[6]   Review on the APP/PS1KI mouse model:: intraneuronal Aβ accumulation triggers axonopathy, neuron loss and working memory impairment [J].
Bayer, T. A. ;
Wirths, O. .
GENES BRAIN AND BEHAVIOR, 2008, 7 :6-11
[7]   APP/PS1KI bigenic mice develop early synaptic deficits and hippocampus atrophy [J].
Breyhan, Henning ;
Wirths, Oliver ;
Duan, Kailai ;
Marcello, Andrea ;
Rettig, Jens ;
Bayer, Thomas A. .
ACTA NEUROPATHOLOGICA, 2009, 117 (06) :677-685
[8]   Massive CA1/2 neuronal loss with intraneuronal and N-interminal truncated Aβ42 accumulation in a novel Alzheimer transgenic model [J].
Casas, C ;
Sergeant, N ;
Itier, JM ;
Blanchard, V ;
Wirths, O ;
van der Kolk, N ;
Vingtdeux, V ;
van de Steeg, E ;
Ret, G ;
Canton, T ;
Drobecq, H ;
Clark, A ;
Bonici, B ;
Delacourte, A ;
Benavides, J ;
Schmitz, C ;
Tremp, G ;
Bayer, TA ;
Benoit, P ;
Pradier, L .
AMERICAN JOURNAL OF PATHOLOGY, 2004, 165 (04) :1289-1300
[9]  
Caston J, 1999, DEV PSYCHOBIOL, V35, P291, DOI 10.1002/(SICI)1098-2302(199912)35:4<291::AID-DEV4>3.0.CO
[10]  
2-U